Pharmacokinetic-Pharmacodynamic and Response Sensitization Modeling of the Intraocular Pressure-Lowering Effect of the EP4 Agonist 5-{3-[(2S)-2-{(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenyl]butyl}-5-oxopyrrolidin-1-yl]propyl}thiophene-2-carboxylate (PF-04475270)<\/title><secondary-title>Journal of Pharmacology and Experimental Therapeutics<\/secondary-title><\/titles><dates><year>2009<\/year><\/dates><electronic-resource-num>10.1124\/jpet.109.157800<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>G. Veinberg<\/author><author>M. Vorona<\/author><author>L. Zvejniece et al.<\/author><\/authors><\/contributors><titles><title>Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.<\/title><secondary-title>Bioorganic & Medicinal Chemistry<\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><electronic-resource-num>10.1016\/j.bmc.2013.03.016<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.7270\/q2n87c5q<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>V. G. Melekhina<\/author><author>A. Komogortsev<\/author><author>B. Lichitsky et al.<\/author><\/authors><\/contributors><titles><title>One-pot synthesis of substituted pyrrolo[3,4-b]pyridine-4,5-diones based on the reaction of N-(1-(4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)-2-oxo-2-arylethyl)acetamide with amines<\/title><secondary-title>Beilstein Journal of Organic Chemistry<\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.3762\/bjoc.15.277<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.beilstein-journals.org\/bjoc\/content\/pdf\/1860-5397-15-277.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>C. Garner<\/author><author>E. Solon<\/author><author>Chii\u2010Ming Lai et al.<\/author><\/authors><\/contributors><titles><title>Role of P-Glycoprotein and the Intestine in the Excretion of DPC 333 [(2R)-2-{(3R)-3-Amino-3-[4-(2-methylquinolin-4-ylmethoxy)phenyl]-2-oxopyrrolidin-1-yl}-N-hydroxy-4-methylpentanamide] in Rodents<\/title><secondary-title>Drug Metabolism And Disposition<\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1124\/dmd.107.017038<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Trong Duc Le<\/author><author>Tien Nguyen Cong<\/author><author>Thi-Minh-Dinh Tran et al.<\/author><\/authors><\/contributors><titles><title>Studying the structure and evaluating \u03b1\u2010glucosidase inhibition of novel acetamide derivatives incorporating 4\u2010ethyl\u20104H\u20101,2,4\u2010triazole starting from 2\u2010(naphthalene\u20101\u2010yl)acetic acid<\/title><secondary-title>Asian Journal of Organic Chemistry<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1002\/ajoc.202400063<\/electronic-resource-num><urls><related-urls><url>https:\/\/onlinelibrary.wiley.com\/doi\/pdfdirect\/10.1002\/ajoc.202400063<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Y. K. Yoon<\/author><author>M. A. Ali<\/author><author>T. S. Choon et al.<\/author><\/authors><\/contributors><titles><title>Ethyl 2-(4-hydroxy-3-methoxyphenyl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1H-benzimidazole-5-carboxylate monohydrate<\/title><secondary-title>Acta Crystallographica Section E<\/secondary-title><\/titles><dates><year>2011<\/year><\/dates><electronic-resource-num>10.1107\/S1600536811052391<\/electronic-resource-num><urls><related-urls><url>https:\/\/journals.iucr.org\/e\/issues\/2012\/01\/00\/is5022\/is5022.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Liu T<\/author><author>Wang J<\/author><author>Zhao Z et al.<\/author><\/authors><\/contributors><titles><title>Efficacy and safety of L-oxiracetam on cognitive function in patients with traumatic brain injury: a multicentre, randomised, double-blind, phase 3 clinical trial.<\/title><secondary-title>Signal transduction and targeted therapy<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.1038\/s41392-025-02492-5<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nature.com\/articles\/s41392-025-02492-5.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Nozari A<\/author><author>Sharma A<\/author><author>Wang Z et al.<\/author><\/authors><\/contributors><titles><title>Co-administration of Nanowired Oxiracetam and Neprilysin with Monoclonal Antibodies to Amyloid Beta Peptide and p-Tau Thwarted Exacerbation of Brain Pathology in Concussive Head Injury at Hot Environment.<\/title><secondary-title>Advances in neurobiology<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1007\/978-3-031-32997-5_7<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Mariia O Shyshkina<\/author><author>Yana I Sakhno<\/author><author>Oleksandr V Radchenko et al.<\/author><\/authors><\/contributors><titles><title>N-tert-Butyl-2-{2-[2-(4-chlorophenyl)-4-hydroxy-1-(5-methylisoxazol-3-yl)-5-oxo-2,5-dihydro-1H-pyrrol-3-yl]-N-(4-methoxyphenyl)acetamido}-2-(4-methoxyphenyl)acetamide methanol monosolvate: single-crystal X-ray diffraction study and Hirshfeld surface analysis<\/title><secondary-title>Acta Crystallographica Section E: Crystallographic Communications<\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1107\/S2056989021011312<\/electronic-resource-num><urls><related-urls><url>https:\/\/journals.iucr.org\/e\/issues\/2021\/12\/00\/zq2268\/zq2268.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Gava R<\/author><author>Schifano F<\/author><\/authors><\/contributors><titles><title>[Oxiracetam].<\/title><secondary-title>Giornale di clinica medica<\/secondary-title><\/titles><dates><year>1989<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Lu Y<\/author><author>Wehner JM<\/author><\/authors><\/contributors><titles><title>Enhancement of contextual fear-conditioning by putative (+\/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-D-aspartate (NMDA) receptor antagonists in DBA\/2J mice.<\/title><secondary-title>Brain research<\/secondary-title><\/titles><dates><year>1997<\/year><\/dates><electronic-resource-num>10.1016\/s0006-8993(97)00644-6<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Cerri A<\/author><author>Farina C<\/author><author>Pinza M et al.<\/author><\/authors><\/contributors><titles><title>Synthesis and nootropic activity of 2-oxo-1-pyrrolidinesulfonic acid derivatives.<\/title><secondary-title>Farmaco (Societa chimica italiana : 1989)<\/secondary-title><\/titles><dates><year>1991<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Fordyce DE<\/author><author>Clark VJ<\/author><author>Paylor R et al.<\/author><\/authors><\/contributors><titles><title>Enhancement of hippocampally-mediated learning and protein kinase C activity by oxiracetam in learning-impaired DBA\/2 mice.<\/title><secondary-title>Brain research<\/secondary-title><\/titles><dates><year>1995<\/year><\/dates><electronic-resource-num>10.1016\/0006-8993(94)01389-y<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Consolo S<\/author><author>Salmoiraghi P<\/author><author>Amoroso D et al.<\/author><\/authors><\/contributors><titles><title>Treatment with oxiracetam or choline restores cholinergic biochemical and pharmacological activities in striata of decorticated rats.<\/title><secondary-title>Journal of neurochemistry<\/secondary-title><\/titles><dates><year>1990<\/year><\/dates><electronic-resource-num>10.1111\/j.1471-4159.1990.tb01909.x<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Wade JP<\/author><\/authors><\/contributors><titles><title>Multi-infarct dementia: prevention and treatment.<\/title><secondary-title>Alzheimer disease and associated disorders<\/secondary-title><\/titles><dates><year>1991<\/year><\/dates><electronic-resource-num>10.1097\/00002093-199100520-00011<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Kometani M<\/author><author>Okada M<\/author><author>Takemori E et al.<\/author><\/authors><\/contributors><titles><title>Effect of oxiracetam on cerebrovascular impairment in rats.<\/title><secondary-title>Arzneimittel-Forschung<\/secondary-title><\/titles><dates><year>1991<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Youn DH<\/author><author>Han SW<\/author><author>Kim JT et al.<\/author><\/authors><\/contributors><titles><title>Oxiracetam alleviates anti-inflammatory activity and ameliorates cognitive impairment in the early phase of traumatic brain injury.<\/title><secondary-title>Acta neurochirurgica<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1007\/s00701-023-05674-8<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Paoli F<\/author><author>Spignoli G<\/author><author>Pepeu G<\/author><\/authors><\/contributors><titles><title>Oxiracetam and D-pyroglutamic acid antagonize a disruption of passive avoidance behaviour induced by the N-methyl-D-aspartate receptor antagonist 2-amino-5-phosphonovalerate.<\/title><secondary-title>Psychopharmacology<\/secondary-title><\/titles><dates><year>1990<\/year><\/dates><electronic-resource-num>10.1007\/BF02245803<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Liang D<\/author><author>Shen J<\/author><author>Jia Y et al.<\/author><\/authors><\/contributors><titles><title>Pharmacokinetic Properties of S-oxiracetam After Single and Multiple Intravenous Infusions in Healthy Volunteers.<\/title><secondary-title>European journal of drug metabolism and pharmacokinetics<\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1007\/s13318-021-00718-9<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Wang C<\/author><author>Li F<\/author><author>Guan Y et al.<\/author><\/authors><\/contributors><titles><title>Bone marrow stromal cells combined with oxiracetam influences the expression of B-cell lymphoma 2 in rats with ischemic stroke.<\/title><secondary-title>Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association<\/secondary-title><\/titles><dates><year>2014<\/year><\/dates><electronic-resource-num>10.1016\/j.jstrokecerebrovasdis.2014.05.035<\/electronic-resource-num><\/record>\n<\/records><\/xml>\n"

"\n\nMolGod<\/database>MOL-GOD<\/source-app>1<\/rec-number>17<\/ref-type>K. Luu<\/author>Eric Zhang<\/author>G. Prasanna et al.<\/author><\/authors><\/contributors>Pharmacokinetic-Pharmacodynamic and Response Sensitization Modeling of the Intraocular Pressure-Lowering Effect of the EP4 Agonist 5-{3-[(2S)-2-{(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenyl]butyl}-5-oxopyrrolidin-1-yl]propyl}thiophene-2-carboxylate (PF-04475270)<\/title><secondary-title>Journal of Pharmacology and Experimental Therapeutics<\/secondary-title><\/titles><dates><year>2009<\/year><\/dates><electronic-resource-num>10.1124\/jpet.109.157800<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>2<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>G. Veinberg<\/author><author>M. Vorona<\/author><author>L. Zvejniece et al.<\/author><\/authors><\/contributors><titles><title>Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.<\/title><secondary-title>Bioorganic & Medicinal Chemistry<\/secondary-title><\/titles><dates><year>2013<\/year><\/dates><electronic-resource-num>10.1016\/j.bmc.2013.03.016<\/electronic-resource-num><urls><related-urls><url>https:\/\/doi.org\/10.7270\/q2n87c5q<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>3<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>V. G. Melekhina<\/author><author>A. Komogortsev<\/author><author>B. Lichitsky et al.<\/author><\/authors><\/contributors><titles><title>One-pot synthesis of substituted pyrrolo[3,4-b]pyridine-4,5-diones based on the reaction of N-(1-(4-hydroxy-6-methyl-2-oxo-2H-pyran-3-yl)-2-oxo-2-arylethyl)acetamide with amines<\/title><secondary-title>Beilstein Journal of Organic Chemistry<\/secondary-title><\/titles><dates><year>2019<\/year><\/dates><electronic-resource-num>10.3762\/bjoc.15.277<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.beilstein-journals.org\/bjoc\/content\/pdf\/1860-5397-15-277.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>4<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>C. Garner<\/author><author>E. Solon<\/author><author>Chii\u2010Ming Lai et al.<\/author><\/authors><\/contributors><titles><title>Role of P-Glycoprotein and the Intestine in the Excretion of DPC 333 [(2R)-2-{(3R)-3-Amino-3-[4-(2-methylquinolin-4-ylmethoxy)phenyl]-2-oxopyrrolidin-1-yl}-N-hydroxy-4-methylpentanamide] in Rodents<\/title><secondary-title>Drug Metabolism And Disposition<\/secondary-title><\/titles><dates><year>2008<\/year><\/dates><electronic-resource-num>10.1124\/dmd.107.017038<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>5<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Trong Duc Le<\/author><author>Tien Nguyen Cong<\/author><author>Thi-Minh-Dinh Tran et al.<\/author><\/authors><\/contributors><titles><title>Studying the structure and evaluating \u03b1\u2010glucosidase inhibition of novel acetamide derivatives incorporating 4\u2010ethyl\u20104H\u20101,2,4\u2010triazole starting from 2\u2010(naphthalene\u20101\u2010yl)acetic acid<\/title><secondary-title>Asian Journal of Organic Chemistry<\/secondary-title><\/titles><dates><year>2024<\/year><\/dates><electronic-resource-num>10.1002\/ajoc.202400063<\/electronic-resource-num><urls><related-urls><url>https:\/\/onlinelibrary.wiley.com\/doi\/pdfdirect\/10.1002\/ajoc.202400063<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>6<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Y. K. Yoon<\/author><author>M. A. Ali<\/author><author>T. S. Choon et al.<\/author><\/authors><\/contributors><titles><title>Ethyl 2-(4-hydroxy-3-methoxyphenyl)-1-[3-(2-oxopyrrolidin-1-yl)propyl]-1H-benzimidazole-5-carboxylate monohydrate<\/title><secondary-title>Acta Crystallographica Section E<\/secondary-title><\/titles><dates><year>2011<\/year><\/dates><electronic-resource-num>10.1107\/S1600536811052391<\/electronic-resource-num><urls><related-urls><url>https:\/\/journals.iucr.org\/e\/issues\/2012\/01\/00\/is5022\/is5022.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>7<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Liu T<\/author><author>Wang J<\/author><author>Zhao Z et al.<\/author><\/authors><\/contributors><titles><title>Efficacy and safety of L-oxiracetam on cognitive function in patients with traumatic brain injury: a multicentre, randomised, double-blind, phase 3 clinical trial.<\/title><secondary-title>Signal transduction and targeted therapy<\/secondary-title><\/titles><dates><year>2025<\/year><\/dates><electronic-resource-num>10.1038\/s41392-025-02492-5<\/electronic-resource-num><urls><related-urls><url>https:\/\/www.nature.com\/articles\/s41392-025-02492-5.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>8<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Nozari A<\/author><author>Sharma A<\/author><author>Wang Z et al.<\/author><\/authors><\/contributors><titles><title>Co-administration of Nanowired Oxiracetam and Neprilysin with Monoclonal Antibodies to Amyloid Beta Peptide and p-Tau Thwarted Exacerbation of Brain Pathology in Concussive Head Injury at Hot Environment.<\/title><secondary-title>Advances in neurobiology<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1007\/978-3-031-32997-5_7<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>9<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Mariia O Shyshkina<\/author><author>Yana I Sakhno<\/author><author>Oleksandr V Radchenko et al.<\/author><\/authors><\/contributors><titles><title>N-tert-Butyl-2-{2-[2-(4-chlorophenyl)-4-hydroxy-1-(5-methylisoxazol-3-yl)-5-oxo-2,5-dihydro-1H-pyrrol-3-yl]-N-(4-methoxyphenyl)acetamido}-2-(4-methoxyphenyl)acetamide methanol monosolvate: single-crystal X-ray diffraction study and Hirshfeld surface analysis<\/title><secondary-title>Acta Crystallographica Section E: Crystallographic Communications<\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1107\/S2056989021011312<\/electronic-resource-num><urls><related-urls><url>https:\/\/journals.iucr.org\/e\/issues\/2021\/12\/00\/zq2268\/zq2268.pdf<\/url><\/related-urls><\/urls><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>10<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Gava R<\/author><author>Schifano F<\/author><\/authors><\/contributors><titles><title>[Oxiracetam].<\/title><secondary-title>Giornale di clinica medica<\/secondary-title><\/titles><dates><year>1989<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>11<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Lu Y<\/author><author>Wehner JM<\/author><\/authors><\/contributors><titles><title>Enhancement of contextual fear-conditioning by putative (+\/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor modulators and N-methyl-D-aspartate (NMDA) receptor antagonists in DBA\/2J mice.<\/title><secondary-title>Brain research<\/secondary-title><\/titles><dates><year>1997<\/year><\/dates><electronic-resource-num>10.1016\/s0006-8993(97)00644-6<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>12<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Cerri A<\/author><author>Farina C<\/author><author>Pinza M et al.<\/author><\/authors><\/contributors><titles><title>Synthesis and nootropic activity of 2-oxo-1-pyrrolidinesulfonic acid derivatives.<\/title><secondary-title>Farmaco (Societa chimica italiana : 1989)<\/secondary-title><\/titles><dates><year>1991<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>13<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Fordyce DE<\/author><author>Clark VJ<\/author><author>Paylor R et al.<\/author><\/authors><\/contributors><titles><title>Enhancement of hippocampally-mediated learning and protein kinase C activity by oxiracetam in learning-impaired DBA\/2 mice.<\/title><secondary-title>Brain research<\/secondary-title><\/titles><dates><year>1995<\/year><\/dates><electronic-resource-num>10.1016\/0006-8993(94)01389-y<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>14<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Consolo S<\/author><author>Salmoiraghi P<\/author><author>Amoroso D et al.<\/author><\/authors><\/contributors><titles><title>Treatment with oxiracetam or choline restores cholinergic biochemical and pharmacological activities in striata of decorticated rats.<\/title><secondary-title>Journal of neurochemistry<\/secondary-title><\/titles><dates><year>1990<\/year><\/dates><electronic-resource-num>10.1111\/j.1471-4159.1990.tb01909.x<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>15<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Wade JP<\/author><\/authors><\/contributors><titles><title>Multi-infarct dementia: prevention and treatment.<\/title><secondary-title>Alzheimer disease and associated disorders<\/secondary-title><\/titles><dates><year>1991<\/year><\/dates><electronic-resource-num>10.1097\/00002093-199100520-00011<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>16<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Kometani M<\/author><author>Okada M<\/author><author>Takemori E et al.<\/author><\/authors><\/contributors><titles><title>Effect of oxiracetam on cerebrovascular impairment in rats.<\/title><secondary-title>Arzneimittel-Forschung<\/secondary-title><\/titles><dates><year>1991<\/year><\/dates><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>17<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Youn DH<\/author><author>Han SW<\/author><author>Kim JT et al.<\/author><\/authors><\/contributors><titles><title>Oxiracetam alleviates anti-inflammatory activity and ameliorates cognitive impairment in the early phase of traumatic brain injury.<\/title><secondary-title>Acta neurochirurgica<\/secondary-title><\/titles><dates><year>2023<\/year><\/dates><electronic-resource-num>10.1007\/s00701-023-05674-8<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>18<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Paoli F<\/author><author>Spignoli G<\/author><author>Pepeu G<\/author><\/authors><\/contributors><titles><title>Oxiracetam and D-pyroglutamic acid antagonize a disruption of passive avoidance behaviour induced by the N-methyl-D-aspartate receptor antagonist 2-amino-5-phosphonovalerate.<\/title><secondary-title>Psychopharmacology<\/secondary-title><\/titles><dates><year>1990<\/year><\/dates><electronic-resource-num>10.1007\/BF02245803<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>19<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Liang D<\/author><author>Shen J<\/author><author>Jia Y et al.<\/author><\/authors><\/contributors><titles><title>Pharmacokinetic Properties of S-oxiracetam After Single and Multiple Intravenous Infusions in Healthy Volunteers.<\/title><secondary-title>European journal of drug metabolism and pharmacokinetics<\/secondary-title><\/titles><dates><year>2021<\/year><\/dates><electronic-resource-num>10.1007\/s13318-021-00718-9<\/electronic-resource-num><\/record>\n<record><database name=\"MolGod\">MolGod<\/database><source-app name=\"MOL-GOD\" version=\"3.1.4\">MOL-GOD<\/source-app><rec-number>20<\/rec-number><ref-type name=\"Journal Article\">17<\/ref-type><contributors><authors><author>Wang C<\/author><author>Li F<\/author><author>Guan Y et al.<\/author><\/authors><\/contributors><titles><title>Bone marrow stromal cells combined with oxiracetam influences the expression of B-cell lymphoma 2 in rats with ischemic stroke.<\/title><secondary-title>Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association<\/secondary-title><\/titles><dates><year>2014<\/year><\/dates><electronic-resource-num>10.1016\/j.jstrokecerebrovasdis.2014.05.035<\/electronic-resource-num><\/record>\n<\/records><\/xml>\n"